John W. Smither - Insider Trading & Ownership

Entity
Individual
Location
C/O Kythera Biopharmaceuticals, Inc., 27200 West Agoura Road, Suite 200, Calabasas, CA
Summary
The estimated net worth of John W. Smither is at least $653K dollars as of August 5, 2024. John W. Smither is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $541K. John W. Smither is the Director of GENELUX Corp and owns shares of GENELUX Corp (GNLX) stock worth about $112K.
All Insider Reports
All Insider Reports

Ownership of John W. Smither

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer $541K Feb 13, 2024
GNLX GENELUX Corp Director $112K Aug 1, 2024
AMTI Applied Molecular Transport Inc. Director Dec 27, 2023
EFTR, EFTRW eFFECTOR Therapeutics, Inc. Director Jun 22, 2023
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director Jan 1, 2024

Insider Transactions Reported by John W. Smither:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.